Clinical Trial: Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06948760) titled 'Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D' on April 21.

Brief Summary: A randomized controlled trial of Control-IQ, assessing glycemic control (time-in-range 70-180 mg/dL) for Lyumjev insulin (in which the insulin settings have been determined using an experimental conversion factor) as compared to Humalog or Novolog (using optimized settings)

Study Start Date: June 09

Study Type: INTERVENTIONAL

Condition: Type 1 Diabetes

Intervention: DEVICE: Control-IQ insulin pump with Lyumjev insulin

Control-IQ insulin pump with insulin using settings ...